Sudhichai Chokekijchai, M.D., FRCP (Thai). 15th, 1960 Nationality: Thai Gender: Marital Status: Single Education: 1990: Fellow of Thai Royal College of Physician, Bangkok Hospital, Mahidol University, Bangkok 1984: B.Sc , Mahidol University, Bangkok Language: Thai, English Address: 17/258 Prachachuen Rd., Tungsonghong, Laksri, Bangkok 1210, Thailand Current Professional Affiliation:
Member of Thai Royal college of Physician Member of Thai Allergy and Immunology Association Member of Thai Infectious Diseases Association
Career history: 1987-1998 Government Official Director Chief Resident, Internal Medicine Staff of Allergy and Immunology Unit
• National Cancer Institute ( 1995-1996), USA
General fellowship (Research in HIV drug) Staff of Allergy and Immunology Unit Sep 1997 to Sep 1998 Bristol-Myers (Thailand) Bangkok, Thailand • Medical Director Sep 1998 to Dec 2000 Eli-Lilly Asia Inc. Thailand Branch Bangkok, Thailand • Medical Director Jan 2001 to Aug 2008 AstraZeneca (Thailand) Ltd. • Medical director Sep 2008 to present Novartis (Thailand) Ltd. • Chief Scientific Officer
1) Xu ZQ, Qiu Y-L Chokekijchai S, Mitsuya H, Zemlicka J. Unsaturated Acyclic Analogues of 2’- Deoxyadenosine and Thymidine Containing Fluoride: synthesis and Biological Activity. Journal of Med. Chem. 1995, 38: 875-882
2) Shirasaka T, Kavlick MK, Ueno T, Gao W-Y, Kojima E, Alcide ML, Chokekijchai S, Roy BM,
Arnold E, Yarchoan R, Mitsuya H. Emergence of Human immunodeficiency Virus Type I Variants with Resistance to Multiple Dideoxynucleosides in Patients Receiving Therapy with Dideoxynucleosides. PNAS 1995, 92: 2398-2402
3) Kojima E, Shirasaka T, Anderson BD, Chokekijchai S, Steinberg SM, Broder S, Yarchoan R,
Mitsuya H. Human Immunodeficeincy Virus type I (HIV-1) Viremia changes and Development of Drug-Related Mutations in Patients with Symptomatic HIV infection Receiving Alternating or Simultaneous Zidovudine and Didanosine Therapy. JID 1995,171: 1152-8
4) Gao W-Y, Johns DG, Chokekijchai S, Mitsuya H. Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2’, 3’-dideoxynucleoside activities against replication of human immunodeficiency virus. PANS 1995, 92: 8333-8337
5) Shirasaka T, Chokekijchai S, Yamada A, Gosselin G, Imbach J-L, Mitsuya H. Comparative Analysis of Anti-Human Immunodeficiency Virus Type I Activities of Dideoxynucleoside Analogs in Resting and Activated Peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 1995, 39: 2555-2559
6) Chokekijchai S, Shirasaka T, Weinstein JN, Mitsuya H. Invitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddl. Antiviral research 1995, 28: 25-38
7) Chokekijchai S, Kojima E, Anderson S, Nomizu M, Tanaka M, Machida M, Date T, Toyota K,
Ishida S, Watanabe K, Yoshioka H, Roller PP, Murakami K, Mitsuya H. NP-06: a Novel Anti- Human Immunodeficeincy Virus Polypeptide produced by a Streptomyces Species. Antimicrobe. Agents Chemother. 1995, 39:2345-2347.
8) Sorbara LR, Maldarelli F, Chamoun G, Schilling B, Chokekijchai S, Staudt L, Mitsuya H, Simpson
IA, Zeichner SL. Human Immunodeficiency Virus Type I Infection of H9 cells Induces Increase Glucose Transporter Expression. Journal of Virology 1996, 70:7275-7279
An appointment has been made for your child to have a food challenge. We hope What happens on the day of the challenge? this information will help you to prepare you and your child for the admission. You will be seen by the specialist nurse and doctor. We will complete some paperwork, check your child’s weight and basic observations, explain the procedure and ask you to sign the consent form
CURRICULUM VITAE PERSONAL INFORMATION Lecturer, Department of Biomedical Engineering International University, Vietnam National Uni RESEARCH INTERESTS Controlled bioavailability of poorly water-soluble drugs, solubilization techniques, and development of nano-drug delivery systems. EDUCATION BACKGROUND From 2008 to 2011: Ph.D. Degree in Pharmaceutics , College of Pharmacy, Kangw